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hospitalization  by Go, AS et al.
Conclusion: Stent-graft placement is an effective option for emergency
repair of descending thoracic aortic perforations.
Summary: The authors evaluated 31 consecutive patients who under-
went catheter-based treatment of perforating lesions of the descending
aorta. Twenty-one patients received treatment of rupture of a descending
thoracic aneurysm or descending thoracic aortic dissection, and 10 patients
received treatment of traumatic disruption of the descending aorta. A total
of 32 endographs were implanted.
Endograft placement was successful in all patients. In 1 patient a second
prosthesis was necessary, because of type I endoleak. Themortality rate at 30
days was 9.7%. One of 3 deaths occurred secondary to type I endoleak and
aortic rupture. All 3 deaths occurred in patients with rupture of a descending
thoracic aneurysm or thoracic dissection. Other complications associated
with placement of the endograft were also more common in patients who
received treatment of a descending thoracic aneurysm or dissection, com-
pared with those who received treatment of traumatic transection of the
descending aorta (28.6% vs 10%). The left subclavian artery was intentionally
covered in 6 patients, without amajor acute adverse event. No complications
were noted secondary to placement of endograft struts into the aortic arch.
There was no paraplegia and no further deaths or ruptures during a mean
follow-up of 17 months.
Comment: Clearly, endograft repair of thoracic aortic disruption is
feasible with excellent short-term results in selected patients. It is still unclear
the percent of patients with acute thoracic disruption who will be eligible for
endograft therapy. Nevertheless, as these devices become more available,
endograft therapy for acute thoracic aortic disruption will be the preferred
treatment in selected patients.
Randomized clinical trial of distal anastomotic interposition vein cuff
and infrainguinal polytetrafluoroethylene (PTFE) bypass grafting
Griffiths GD, Nagy J, Black D, et al. Br J Surg 2004;91:560-2.
Conclusion: Three-year patency rates for femoral to below-knee pop-
liteal polytetrafluoroethylene (PTFE) bypasses are improved with use of a
Miller cuff. Miller cuffs have no effect on patency rates for femoral to
above-knee popliteal bypasses at 5 years, and do not improve limb salvage in
either above-knee or below-knee PTFE bypasses.
Summary: The authors examined the effect of a Miller vein cuff at the
distal anastomosis of a PTFE graft on median to long-term patency of
femoral to above-knee and femoral to below-knee bypasses. Outcome
measures were bypass graft patency and limb salvage. This was a prospective,
randomized clinical trial with 261 bypass operations originally randomized.
Data were available for 235 bypasses (120 with a Miller cuff, 115 without).
Mean age of patients in the cuff group was 67.2 years, and in the non-cuff
group was 69.3 years (P  .72). The indication for operation was limb
salvage in 89% of each group. Cumulative 5-year patency for above-knee
bypasses with a Miller cuff was 40%, compared with 42% for the non-cuffed
bypasses (P  .702). Cumulative 3-year patency for below-knee bypasses
with aMiller cuff was 45%, compared with 19% for non-cuffed bypasses (P
.018). The Miller cuff had no significant effect on limb salvage for either
above-knee or below-knee bypasses.
Comment:When PTFE bypass is indicated to the below-knee popliteal
artery in a primarily limb salvage population, a Miller cuff should be used.
The results also suggest that PTFE bypass to the popliteal artery for limb
salvage, whether above or below the knee, has relatively poor long-term
patency.
Chronic kidney disease and the risks of death, cardiovascular events,
and hospitalization
Go AS, Chertow GM, Fan D, et al. N Engl J Med 2004;351:1296-1305.
Conclusion: Progressive levels of renal insufficiency substantially in-
crease the risk for death or cardiovascular disease, and use of healthcare
resources. The effect is more marked with end-stage renal disease than with
milder levels of renal insufficiency.
Summary: The authors estimated longitudinal glomerular filtration
rate (GFR) in 1,120,295 adults in the Renal Registry of Kaiser Permanente
of Northern California. In patients in the registry, 1 or more outpatient
determinations of serum creatinine levels were made between January 1,
1996, and December 31, 2000. Excluded were patients with kidney trans-
plants and those receiving maintenance dialysis. Multivariable analysis was
used to examine the association between estimated GFR and the risk for
death, cardiovascular events, and hospitalization.
Median follow-up was 2.84 years. Mean patient age was 52 years; 55%
of patients were women. After adjustment, risk for death increased as GFR
decreased below 60 mL/min/1.73m2 of body surface area. The adjusted
hazard ratio for death was 1.2 with an estimated GFR of 45 to 59 mL/min/
1.73m2 (95% confidence interval [CI], 1.1-1.2), 1.8 with an estimated GFR
of 30 to 45mL/min/1.73m2 (95%CI, 1.7-1.9), 3.2 with an estimatedGFR
of 15 to 29 mL/min/1.71m2 (95% CI, 3.1-3.4), and 5.9 with an estimated
GFR less than 15mL/min/1.73m2 (95% CI, 5.4-6.5). Adjusted hazard
ratios for cardiovascular events also increased inversely with estimated GFR:
1.4 (95%CI, 1.4-1.5), 2.0 (95%CI, 1.9-2.1), 2.8 (95%CI, 2.6-2.9), and 3.4
(95% CI, 3.1-3.8), respectively. Risk for hospitalization also correlated with
reduced estimates of GFR.
Comment: Chronic renal disease, even when it does not necessitate
dialysis, has considerable adverse effects. While prevention of end-stage renal
disease is clearly important, more effective management of milder levels of
renal insufficiency is also needed to reduce the adverse health effects of lesser
levels of impaired renal function.
Below-knee elastic compression stockings to prevent the post-
thrombotic syndrome: A randomized, controlled trial
Prandoni P, Lensing AWA, Prins MH, et al. Ann Intern Med 2004;141:
249-56.
Conclusion: Below-knee elastic compression stockings reduce devel-
opment of postthrombotic syndrome in almost half of patients with proxi-
mal deep venous thrombosis (DVT).
Summary: The authors sought to evaluate the ability of elastic com-
pression stockings to prevent postthrombotic syndrome in patients with
acute proximal DVT. This randomized, controlled trial, conducted in a
university hospital in Italy, included 180 consecutive patients with a first
episode of symptomatic proximal DVT treated with conventional anticoag-
ulation therapy. Before discharge, patients were randomly assigned to use
below-knee elastic compression stockings (30-40 mmHg at the ankle) for 2
years. Follow-up extended up to 5 years. Presence and severity of postthrom-
botic syndrome was scored with a standardized scale.
Sequela of postthrombotic syndrome developed in 44 of 90 control
patients, and was severe in 10. Sequela of postthrombotic syndrome devel-
oped in 23 of 90 patients wearing elastic stockings, and was severe in 3. The
cumulative incidence of postthrombotic syndrome in the control group
versus the elastic stocking group was 40.0% (95% confidence interval [CI],
29.9-50.1) versus 21.1% (95% CI, 12.7-29.5) after 6 months, 46.7% (95%
CI, 36.4-57.0) versus 22.2% (95% CI, 13.8-30.7) after 1 year, and 49.1%
(95% CI, 38.7-59.4) versus 24.5% (95% CI, 15.6-33.4) after 2 years. The
hazard ratio for postthrombotic syndrome in the elastic compression stock-
ings group compared with the control group was 0.49 (CI, 0.29-0.84; P 
.011).
Comment: This study and a previous study by Brandjes et al (Lancet
1997;349:759-62) indicate a beneficial effect of prophylactic elastic com-
pression stockings in preventing postthrombotic syndrome in patients with
symptomatic proximal DVT. Patients with proximal DVT should use elastic
compression stockings to reduce the incidence of postthrombotic syndrome.
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